AI English summary of an SEC filing — figures as filed
DuPont said net sales for Q1 2025 rose 5% to $3,066 million, and organic sales grew 6%. GAAP loss from continuing operations was $(548) million, or $(1.33) per share.
Key points
AI summaryDuPont said net sales for Q1 2025 rose 5% to $3,066 million, and organic sales grew 6%. GAAP loss from continuing operations was $(548) million, or $(1.33) per share.
The company said its GAAP loss from continuing operations for Q1 stemmed from a $768 million non-cash goodwill impairment charge related to the Aramids reporting unit. The company explained that the impairment resulted from the impairment analysis it performed as it redefined reporting units in the 2025 Segment Realignment.
The company said ElectronicsCo net sales rose 14% to $1,118 million and its operating EBITDA was $373 million. IndustrialsCo net sales were flat at $1,948 million, with organic sales up 2% and operating EBITDA of $464 million.
The company said cash provided by operating activities from continuing operations for Q1 was $382 million, capital expenditures were $249 million, and separation transaction cost payments were $79 million, resulting in transaction-adjusted free cash flow of $212 million. The company said its full-year 2025 outlook is unchanged from its prior outlook.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.
DuPont Q1 net sales of $3,066 million; GAAP loss from continuing operations of $(548) million
DuPont said net sales for Q1 2025 rose 5% to $3,066 million, and organic sales grew 6%. GAAP loss from continuing operations was $(548) million, or $(1.33) per share.
Source · Based on the filing body and exhibits
$768 million goodwill impairment at Aramids unit
The company said its GAAP loss from continuing operations for Q1 stemmed from a $768 million non-cash goodwill impairment charge related to the Aramids reporting unit. The company explained that the impairment resulted from the impairment analysis it performed as it redefined reporting units in the 2025 Segment Realignment.
Source · Based on the filing body and exhibits
Net sales and operating EBITDA by segment
The company said ElectronicsCo net sales rose 14% to $1,118 million and its operating EBITDA was $373 million. IndustrialsCo net sales were flat at $1,948 million, with organic sales up 2% and operating EBITDA of $464 million.
Source · Based on the filing body and exhibits
Q1 free cash flow and full-year outlook maintained
The company said cash provided by operating activities from continuing operations for Q1 was $382 million, capital expenditures were $249 million, and separation transaction cost payments were $79 million, resulting in transaction-adjusted free cash flow of $212 million. The company said its full-year 2025 outlook is unchanged from its prior outlook.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…